SVRA stock forecast
Our latest prediction for Savara, Inc.'s stock price was made on the April 8, 2019 when the stock price was at 9.03$.
In the short term (2weeks), SVRA's stock price should underperform the market by -0.03%. During that period the price should oscillate between -8.22% and +10.57%.
In the medium term (3months), SVRA's stock price should outperform the market by 2.68%. During that period the price should oscillate between -18.79% and +29.33%.Get email alerts
About Savara, Inc.
Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.85$ per share.
The book value per share is 2.36$
Three months stock forecastApril 8, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|